NCT02020707 2024-07-26
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers
Mayo Clinic
Phase 1 Completed
Mayo Clinic
Seagen Inc.
SCRI Development Innovations, LLC
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Genta Incorporated